The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
HIF-Dependent Antitumorigenic Effect of Antioxidants In Vivo
Open accessAbstract
The antitumorigenic activity of antioxidants has been presumed to arise from their ability to squelch DNA damage and genomic instability mediated by reactive oxygen species (ROS). Here, we report that antioxidants inhibited three tumorigenic models in vivo. Inhibition of a MYC-dependent human B lymphoma model was unassociated with genomic instability but was linked to diminished hypoxia-inducible factor (HIF)-1 levels in a prolyl hydroxylase 2 and von Hippel-Lindau protein-dependent manner. Ectopic expression of an oxygen-independent, stabilized HIF-1 mutant rescued lymphoma xenografts from inhibition by two antioxidants: N-acetylcysteine and vitamin C. These findings challenge the paradigm that antioxidants diminish tumorigenesis primarily through decreasing DNA damage and mutations and provide significant support for a key antitumorigenic effect of diminishing HIF levels.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Interestingly, our NAC treated scramble shRNA expressing cells did form tumors, which is not consistent with the aforementioned study.”
From SirT3 suppresses hypoxia inducible factor 1α and tumor growth by inhibiting mitochondrial ROS production (2011) · cites this paper as Gao et al., 2007
In the citing paper
“Previously it was reported that NAC administration completely inhibits tumor formation in xenograft models (Gao et al., 2007).”
From SirT3 suppresses hypoxia inducible factor 1α and tumor growth by inhibiting mitochondrial ROS production (2011) · cites this paper as Gao et al., 2007
In the citing paper
“ROS signals are sufficient to trigger the stabilization of HIFα (21, 31), and a recent study indicates that antioxidant therapy significantly inhibits tumor progression in vivo by inhibiting HIF activation (18).”
From Loss of the SdhB, but Not the SdhA, Subunit of Complex II Triggers Reactive Oxygen Species-Dependent Hypoxia-Inducible Factor Activation and Tumorigenesis (2008) · cites this paper as [18]
In the citing paper
“there is growing evidence that HIF1α-dependent tumour growth may be inhibited by ascorbate78,79.”
From Targeting cancer vulnerabilities with high-dose vitamin C (2019) · cites this paper as [79]
In the citing paper
“In a mouse model of myc-driven tumorigenesis, tumor growth is inhibited by treatment with antioxidants 70.”
From Mitochondrial reactive oxygen species regulate cellular signaling and dictate biological outcomes (2010) · cites this paper as [70]
In the citing paper
“However, the effect of antioxidant treatment was a result of the inhibition of HIF accumulation: expression of a stable HIF mutant alone could provide resistance to antioxidant treatment.”
From Mitochondrial reactive oxygen species regulate cellular signaling and dictate biological outcomes (2010) · cites this paper as [70]
Citations
Cites
Targeting HIF-1 for cancer therapy
Semenza, G. L. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1187 · Cited by 6,717
Self-citationHypoxia signalling in cancer and approaches to enforce tumour regression
Pouysségur, J., Dayan, F., & Mazure, N. M. (2006) · Nature · doi:10.1038/nature04871 · Cited by 1,676
Mitochondrial complex III is required for hypoxia-induced ROS production and cellular oxygen sensing
Guzy, R. D., Hoyos, B., Robin, E., Chen, H., Liu, L., Mansfield, K. D., Simon, M. C., Hammerling, U., & Schumacker, P. T. (2005) · Cell Metabolism · doi:10.1016/j.cmet.2005.05.001 · Cited by 1,545
Differential Roles of Hypoxia-Inducible Factor 1α (HIF-1α) and HIF-2α in Hypoxic Gene Regulation
Hu, C.-J., Wang, L.-Y., Chodosh, L. A., Keith, B., & Simon, M. C. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.24.9361-9374.2003 · Cited by 1,386
Berra, E., Benizri, E., Ginouvès, A., Volmat, V., Roux, D., & Pouysségur, J. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg392 · Cited by 1,348
The antioxidant function of the p53 tumor suppressor
Sablina, A. A., Budanov, A. V., Ilyinskaya, G. V., Agapova, L. S., Kravchenko, J. E., & Chumakov, P. M. (2005) · Nature Medicine · doi:10.1038/nm1320 · Cited by 1,137
A Biologic Definition of Burkitt's Lymphoma from Transcriptional and Genomic Profiling
Hummel, M., Bentink, S., Berger, H., Klapper, W., Weßendorf, S., Barth, T. F. E., Bernd, H., Cogliatti, S., Dierlamm, J., Feller, A. C., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa055351 · Cited by 1,002
Zhang, H., Gao, P., Fukuda, R., Kumar, G., Krishnamachary, B., Zeller, K. I., Dang, C. V., & Semenza, G. L. (2007) · Cancer Cell · doi:10.1016/j.ccr.2007.04.001 · Cited by 885
Self-citationc-Myc Can Induce DNA Damage, Increase Reactive Oxygen Species, and Mitigate p53 Function
Vafa, O., Wade, M., Kern, S., Beeche, M., Pandita, T. K., Hampton, G. M., & Wahl, G. M. (2002) · Molecular Cell · doi:10.1016/s1097-2765(02)00520-8 · Cited by 876
HIF-2α Promotes Hypoxic Cell Proliferation by Enhancing c-Myc Transcriptional Activity
Gordan, J. D., Bertout, J. A., Hu, C.-J., Diehl, J. A., & Simon, M. C. (2007) · Cancer Cell · doi:10.1016/j.ccr.2007.02.006 · Cited by 781
Cited by
Sorted by citations
Items 401–500 of 523
Bedessem, B., & Stéphanou, A. (2014) · PLoS ONE · doi:10.1371/journal.pone.0110495 · Cited by 11
The effect ofN-acetylcysteine on the antitumor activity of ifosfamide
Chen, N., Hanly, L., Rieder, M. J., Yeger, H., & Koren, G. (2011) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/y11-028 · Cited by 9
Targeting ROS for Cancer Therapy
Dong, J., & Liu, B. (2016) · Chemotherapy Open access · doi:10.4172/2167-7700.1000199 · Cited by 9
Regulation of cancer cell metabolism
Gao, P., & Wei, H. (2017) · Scientia Sinica Vitae · doi:10.1360/n052016-00334 · Cited by 8
Self-citationUbiquitination of transcription factors in cancer: unveiling therapeutic potential
Kim, D., Nam, H. J., & Baek, S. H. (2025) · Molecular Oncology · doi:10.1002/1878-0261.70033 · Cited by 9
Mishra, M., Jayal, P., Karande, A. A., & Chandra, N. R. (2018) · FEBS Journal · doi:10.1111/febs.14641 · Cited by 8
Torricelli, P. (2013) · American Journal of Life Sciences · doi:10.11648/j.ajls.20130101.14 · Cited by 8
ROS, Redox Regulation, and Anticancer Therapy
Bansal, M. P. (2023) · Springer eBooks · doi:10.1007/978-981-99-7342-2_9 · Cited by 7
Newly Designed Cysteine-Based Self-Assembling Prodrugs for Sepsis Treatment
Koda, Y., & Nagasaki, Y. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15061775 · Cited by 7
Organ Culture Model of Liver for the Study of Cancer Treatment for Hepatocellular Carcinoma
Piera, T. (2016) · Cancer Research Journal · doi:10.11648/j.crj.20160402.13 · Cited by 7
Ou, C., Liu, L., Wang, J., Dai, S., Qu, Y., Xiong, Y., Xi, W., Xu, J., & Guo, J. (2017) · Urologic Oncology Seminars and Original Investigations · doi:10.1016/j.urolonc.2017.05.016 · Cited by 7
Zakaria, S., Nawaya, R. A., Abdel‐Hamid, N. M., El-Domany, R. A., & El‐Shishtawy, M. M. (2021) · Current Cancer Drug Targets · doi:10.2174/1568009621666210811121120 · Cited by 7
Zhang, J., Zhang, Q., Lin, G., Wang, Y., Li, J., Wang, P., Qi, J., Liang, Y., He, S., Gong, Y., et al. (2025) · Advanced Science · doi:10.1002/advs.202501011 · Cited by 6
Shimizu, D., KANDA, M., Kishida, T., Nakamura, S., Sasahara, M., Ueda, S., Sato, Y., Inokawa, Y., Hattori, N., Hayashi, M., et al. (2023) · Cancer Genomics & Proteomics · doi:10.21873/cgp.20386 · Cited by 6
Hoang, G., Zhang, C., Attarwala, N., Jung, J. G., Cooper, A. J. L., & Le, A. (2021) · Analytical Biochemistry · doi:10.1016/j.ab.2021.114206 · Cited by 6
The Key Network of mRNAs and miRNAs Regulated by HIF1A in Hypoxic Hepatocellular Carcinoma Cells
Liu, T., Tang, J. Y., Li, X., Lin, Y., Yang, Y., Ma, K., Hui, Z., Ma, H., Qin, Y., Lei, H., et al. (2022) · Frontiers in Genetics · doi:10.3389/fgene.2022.857507 · Cited by 6
Regulators of the Hypoxic Response: A Growing Family
Bridge, K. S., & Sharp, T. V. (2012) · Future Oncology · doi:10.2217/fon.12.46 · Cited by 6
Sulaiman, S. H., Omer, R. A., Barzani, K. I. S., Barzani, H. A. H., Ashfaq, M., Smerat, A., & Feizi‐Dehnayebi, M. (2026) · Chemical Physics Impact · doi:10.1016/j.chphi.2026.101054 · Cited by 6
Lv, H., Yang, H., Duan, Y., Sha, H., & Zhao, Z. (2023) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-023-02906-7 · Cited by 5
Wang, P., Zheng, D., Qi, H., & Gao, Q. (2021) · Cancer Biomarkers · doi:10.3233/cbm-203112 · Cited by 5
Apoptotic signaling through reactive oxygen species in cancer cells
Kim, D., Park, G. B., & Hur, D. Y. (2014) · World Journal of Immunology · doi:10.5411/wji.v4.i3.158 · Cited by 5
Anticancer Effects of Ascorbic Acid: Not All Sides Fit All
Arunsi, U. O., Olugbami, J. O., & Oyelere, A. K. (2025) · Cancers · doi:10.3390/cancers17172877 · Cited by 4
Niosomes loading N-acetyl-L-cysteine for cancer treatment in vivo study
Mohamad, E. A., Ali, A. A., Sharaky, M. M., & El-Gebaly, R. H. (2023) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-023-02893-9 · Cited by 4
Nakai, A., Lee, D., Shoda, C., Negishi, K., Nakashizuka, H., Yamagami, S., & Kurihara, T. (2023) · Journal of Ophthalmology · doi:10.1155/2023/6617981 · Cited by 4
Research progress of mitochondria and cytoskeleton crosstalk in tumour development
Ji, Y., Lin, Y., He, J. H., Xie, Y., An, W., Luo, X., Qiao, X., & Li, Z. (2024) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2024.189254 · Cited by 4
Lu, H., Zhu, Y., Liu, W., Yan, Y., Jiang, X., Wang, Q., Zhao, Y., He, M., & Wei, M. (2022) · Current Medicinal Chemistry · doi:10.2174/0929867329666220829095334 · Cited by 5
Impact of Static Magnetic Fields on Cells
Ji, X., & Zhang, X. (2023) · Springer eBooks · doi:10.1007/978-981-19-8869-1_6 · Cited by 4
Dehydroascorbic Acid Adducts of Guanosine Residues: Possible Biological Implications
Raza, A., & Vince, R. (2011) · ChemBioChem · doi:10.1002/cbic.201000748 · Cited by 4
3.3 Mitochondrial Energy Production
Yalçınkaya, B. H., Genç, S., Çatak, J., Özilgen, M., & Yılmaz, B. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-809597-3.00308-4 · Cited by 4
Anti-tumor mechanism and influencing factors of clinical efficacy of high-dose vitamin C treatment
Wang, S., Qu, J., He, J., Zhao, Y., Yu, S., & Rao, B. (2024) · Precision Nutrition · doi:10.1097/pn9.0000000000000083 · Cited by 4
de Klerk, D. J., de Keijzer, M. J., Franchi, L. P., Tian, J., Gureev, M., Ge, Y., Mesquita, B. S., Saelman, G., herteryck, I. V., Dias, L. M., et al. (2025) · Biochemical Pharmacology · doi:10.1016/j.bcp.2025.117620 · Cited by 3
Lo, C., Wang, C., Lin, C., Lin, T., Chang, P., Lo, Y., Wang, T., Huang, T., He, J., Heh, C., et al. (2025) · British Journal of Pharmacology · doi:10.1111/bph.70157 · Cited by 3
Singh, R., Parchwani, D. N., Sharma, G., & Sharma, P. (2025) · Indian Journal of Clinical Biochemistry · doi:10.1007/s12291-025-01341-0 · Cited by 3
Miao, T., Yang, D., Gao, L.-J., Yin, J., Zhu, Q., Liu, J., He, Y., & Chen, X. (2022) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2022.942402 · Cited by 3
Metabolic Recycling Enhances Proliferation in MYC‐Transformed Lymphoma B Cells
Zhang, C., Hoang, G., Attarwala, N., Cooper, A. J. L., Asaka, R., & Le, A. (2022) · Advanced Biology · doi:10.1002/adbi.202200233 · Cited by 3
Dual Role of DUOX1-Derived Reactive Oxygen Species in Melanoma
Pardo-Sánchez, I., Ibáñez‐Molero, S., García‐Moreno, D., & Mulero, V. (2023) · Antioxidants · doi:10.3390/antiox12030708 · Cited by 3
Lv, H., Yang, H., Duan, Y., Yan, C., Li, G., Zhao, G., Sun, F., Feng, Y., Li, Y., Fu, Y., et al. (2024) · Journal of drug targeting · doi:10.1080/1061186x.2024.2374037 · Cited by 3
Janssens, L. K., & Stove, C. P. (2024) · Biochemical Pharmacology · doi:10.1016/j.bcp.2024.116478 · Cited by 3
Vitamin C: epigenetic roles and cancer
Mustafi, S., & Wang, G. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-811907-5.00003-8 · Cited by 4
NADPH promotes the rapid growth of the tumor
Hao, S. P. (2018) · Infection International/Infection International (Electronic Edition) · doi:10.1515/ii-2017-0164 · Cited by 3
High Doses of Vitamin C and Leukemia: In Vitro Update
Mastrangelo, D., Massai, L., Fioritoni, G., Lo‐Coco, F., Noguera, N. I., & Testa, U. (2018) · InTech eBooks · doi:10.5772/intechopen.71484 · Cited by 3
Khafagy, A., Eid, S., & Mohammed, R. N. (2019) · Suez Canal Veterinary Medicine Journal SCVMJ · doi:10.21608/scvmj.2019.58666 · Cited by 3
The role of ascorbate in the regulation of HIF-1 in cancer cells
Kuiper, C. (2013) · Otago University Research Archive (University of Otago) · Cited by 2
Samanta, D., Gilkes, D. M., Xiang, L., Chaturvedi, P., & Semenza, G. L. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.06.27.497729 · Cited by 4
Self-citationKim, R. J., & Park, H. B. (2024) · Antioxidants · doi:10.3390/antiox13040497 · Cited by 2
Ricol, M., Lipinski, O., Moali, C., & Sée, V. (2026) · Matrix Biology · doi:10.1016/j.matbio.2026.102007 · Cited by 3
Ивановна, Л. Е., Masalova, O. V., Permyakova, K. Y., Kozlov, V. V., Nikolaeva, T. N., Pronin, A. V., Треворович, В.-Э. В., Ivanov, A. V., & Aa, K. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22136892 · Cited by 2
Anti‑tumor properties of FoxO1 in YD‑9 oral squamous cell carcinoma cells
Kim, Y., Seong, C., Cho, K.-A., Lee, S., Kim, T., Kim, H. C., Cho, J., Jung, W. S., Jang, S., Shin, J., et al. (2023) · Oncology Reports · doi:10.3892/or.2023.8559 · Cited by 2
Cancer Metabolism: A Nexus of Matter, Energy, and Reactive Oxygen Species
Bingham, P. M., Stuart, S. D., & Zachar, Z. (2014) · Cancer drug discovery and develogment/Cancer drug discovery and development · doi:10.1007/978-1-4614-9545-1_2 · Cited by 2
Witamina C w leczeniu nowotworów i profilaktyce chorób niezakaźnych
Kalemba-Drożdż, M. (2018) · Państwo i Społeczeństwo · doi:10.31749/pismzp2018/20848 · Cited by 2
The Role of Mitochondrial Reactive Oxygen Species in Cancer
Dakubo, G. D. (2010) · Springer eBooks · doi:10.1007/978-3-642-11416-8_10 · Cited by 2
Park, H. (2008) · Toxicological Research · doi:10.5487/tr.2008.24.2.101 · Cited by 2
Antioxidant Enzyme Activities in Ascorbic Acid and Selenium Applied Hepatocellular Carcinoma Cells
BALKAN, B. M., Meral, Ö., Kısmalı, G., & Sel, T. (2020) · Journal of the Turkish Chemical Society Section A Chemistry · doi:10.18596/jotcsa.724117 · Cited by 2
Use of vitamin C in anticancer therapy? – preclinical and clinical data overview
Regulska, K., & Litwiniuk, M. M. (2020) · Farmacja Polska · doi:10.32383/farmpol/123816 · Cited by 2
Metabolic Imbalance Associated Mitophagy in Tumor Cells: Genesis and Implications
Chaurasia, M., Misra, S., Bhatt, A. N., Das, A., Dwarakanath, B. S. R., & Sharma, K. (2015) · Journal of cancer research updates · doi:10.6000/1929-2279.2015.04.02.8 · Cited by 2
Nezami, M. A., Hager, S. J., & Garner, J. (2016) · Journal of Cancer Therapy · doi:10.4236/jct.2016.74027 · Cited by 2
Johansson, K. (2010) · Figshare · Cited by 1
Beebe, S. J. (2021) · Series in bioengineering · doi:10.1007/978-981-10-5113-5_8 · Cited by 1
Mechanism of oxidative stress in carcinogenesis induced by xenobiotics
Srivastava, A. K., Kumar, D., Singh, D. R., & Singh, R. K. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-90560-2.00003-0 · Cited by 1
Genetic overlap and causal inferences between diet-derived antioxidants and small-cell lung cancer
Li, X., Mo, X., Li, H., Weng, X., Wang, D., & Zhang, W. (2024) · Medicine · doi:10.1097/md.0000000000037206 · Cited by 1
Reactive Oxygen Species (ROS) and Cancer
Soni, J. P., Sood, R., & Kumar, J. (2024) · Cancer drug discovery and develogment/Cancer drug discovery and development · doi:10.1007/978-3-031-66421-2_2 · Cited by 1
Bashir, M., Murtada, A., Jubouri, M., Awad, W. I., Williams, I., & Bailey, D. M. (2025) · Experimental Physiology · doi:10.1113/ep092898 · Cited by 1
Saitoh, Y., Tanimura, Y., Ueda, S., Furuhata, T., Takeda, M., Okawachi, K., & Fukukita, Y. (2026) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2026.130908 · Cited by 1
Effect of Oxidative Stress on Matrix Remodeling and Diseases
Mukherjee, S., Vichare, A., & Majumder, A. (2026) · Biology of extracellular matrix · doi:10.1007/978-3-032-22618-1_9 · Cited by 1
Lung Tumor Microenvironment and Myelomonocytic Cells
Srivastava, M. K., Andersson, Å., Zhu, L., Harris‐White, M. E., Jay, M., Dubinett, S. M., & Sharm, S. (2012) · InTech eBooks · doi:10.5772/33119 · Cited by 1
Molecular Aspects of the Warburg Effect
Balding, E., Ververis, K., & Karagiannis, T. C. (2014) · Springer eBooks · doi:10.1007/978-1-4939-0706-9_13 · Cited by 1
Patient-Specific Modeling of Hypoxic Response and Microvasculature Dynamics
Nathan, J. C., & Qutub, A. A. (2010) · Springer eBooks · doi:10.1007/978-1-4419-6691-9_11 · Cited by 1
Maru, Y. (2021) · Springer eBooks · doi:10.1007/978-981-16-1757-7_16 · Cited by 1
Effects of Curcumin on Changes in Spermatogenetic Cells of Rats Treated with Cisplatin
Şentürk, Ş., & Sandıkçı, M. (2022) · Medical Laboratory Technology Journal · doi:10.31964/mltj.v8i1.483 · Cited by 1
Prendergast, G. C., Metz, R. A., Chang, M. Y., Smith, C., Muller, A. J., & Ostrand‐Rosenberg, S. (2011) · Springer eBooks · doi:10.1007/978-1-4614-0662-4_7 · Cited by 1
Mitochondrial and Free Radical Metabolism – Biological and Pathological Implications
Duluc, L., Andriantsitohaina, R., & Simard, G. (2014) · Springer eBooks · doi:10.1007/978-3-642-30018-9_7 · Cited by 1
Pu, N., Liu, S., Bai, X., Yang, J., Qian, T., Wei, Z., Ma, T., Cai, L., & Wu, W. (2023) · Cancer Screening and Prevention · doi:10.14218/csp.2023.00001 · Cited by 1
HIF‐1 Inhibitors for Cancer Therapy
Rapisarda, A., & Melillo, G. (2010) · Wiley eBooks · doi:10.1002/9780470669891.ch17 · Cited by 1
The Genetic and Proteomic Detereminants of the Risk of Coronary Artery Disease
Almontashiri, N. A. M. (2015) · uO Research (University of Ottawa) · doi:10.20381/ruor-6541 · Cited by 1
Yang, C. (2014) · Digital Commons-TMC (Texas Medical Center) · Cited by 1
Maru, Y. (2016) · Springer eBooks · doi:10.1007/978-4-431-56024-1_16 · Cited by 1
Bu, Q., Deng, Y., Wang, Q., Deng, R., Hu, S., Pei, Z., & Zhang, Y. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.05.15.540796 · Cited by 1
Intricate Link between Hypoxia and Oxidative Stress in Chronic Kidney Disease
Tanaka, T. (2010) · Humana Press eBooks · doi:10.1007/978-1-60761-857-7_24
Regulation of Myc oncoprotein function by E3 ubiquitin ligases
Fahlén, S. (2008) · Epsilon Open Archive (Sveriges lantbruksuniversitet biblioteket (Swedish University of Agricultural Sciences))
Hanly, L. (2013) · Scholarship@Western (Western University)
Chiarugi, P., Taddei, M. L., & Giannoni, E. (2015) · Oxidative stress in applied basic research and clinical practice · doi:10.1007/978-3-319-15539-5_1
Sharifi, N., Hurt, E. M., Thomas, S., & Farrar, W. L. (2008) · European Journal of Cancer Supplements · doi:10.1016/s1359-6349(08)72094-9
Poschke, I. C. (2011) · Figshare
Therapeutic Targeting of MYC and HIF Networks in Cancer
Dang, C. V. (2009) · Journal of Medical Sciences · doi:10.2174/1996327000902020046
Self-citationAmini, A., Masoumi-Moghaddam, S., & Morris, D. L. (2016) · Springer eBooks · doi:10.1007/978-3-319-28570-2_5
Innate Immune Responses and Cancer Metastasis
Maru, Y. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-801968-9.00006-4
Diffuse large B-cell lymphoma: Biological prognostic factors and treatment with anti-cd20 antibody
Gomes, M., & Prı́ncipe, F. (2014) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT)
Investigation into the Role of Antioxidants in Tumorigenesis
Harris, I. S. (2014) · Library and Archives Canada (Government of Canada)
The Implication of Antiangiogenic Treatment of Malignancies on Human Metabolism
Obad, N., & Bjerkvig, R. (2017) · Springer eBooks · doi:10.1007/978-3-319-31215-6_35-1
Additional Therapies and Innovative Technologies
O’Brien, K., & Sali, A. (2017) · Springer eBooks · doi:10.1007/978-3-319-56632-0_7
Age-related host factors regulate lung cancer progression.
Greenwell, J. C. (2017) · ThinkIR: The University of Louisville's Institutional Repository (University of Louisville) · doi:10.18297/etd/2846
Franklin, E. R. (2018) · Queensland University of Technology · doi:10.5204/thesis.eprints.121736
The expression of neuroglobin in astrocytoma
Zhang, H. Q. G., ZhangMingyuan, L., & Guan, L. (2012)
Self-citationOxidative Stress, Microenvironment, and Oral Cancer
Sarode, G. S., Maniyar, N., Sarode, S. C., & Mamatha, G. S. (2021) · Springer eBooks · doi:10.1007/978-981-15-4501-6_10-1
ESBLおよびメタロβラクタマーゼスクリーニング用試薬(シカベータテスト)の使用経験
山口育男, 神谷加奈子, 木下恵子, 小島, 克., 谷山夕紀衣, 青木由利子, & 山下峻徳 (2005) · 医学検査
Maru, Y. (2016) · Springer eBooks · doi:10.1007/978-4-431-56024-1_10
Maru, Y. (2021) · Springer eBooks · doi:10.1007/978-981-16-1757-7_10
Oxidative Stress, Microenvironment, and Oral Cancer
Sarode, G. S., Maniyar, N., Sarode, S. C., & Mamatha, G. S. (2022) · Springer eBooks · doi:10.1007/978-981-15-9411-3_10
Metadata
- Authors
- Gao, P., Zhang, H., Dinavahi, R., Li, F., Xiang, Y., Raman, V., Bhujwalla, Z. M., Felsher, D. W., Cheng, L., Pevsner, J., Lee, L. A., Semenza, G. L., & Dang, C. V.
- Affiliations
- Johns Hopkins University (US)
- Stanford Medicine (US)
- Corresponding author
- Dang, Chi V.
- ORCID
- Venue
- Cancer Cell
- Publisher
- Elsevier BV
- Published
- 2007-09
- Volume
- 12
- Issue
- 3
- Pages
- 230-238
- ISSN
- 1535-6108 (ISSN-L)
- PMC
- PMC2084208
- OpenAlex
- W2143182501
- Cited by
- 523
- References
- 41
- Citations by year
- 2026: 8 · 2025: 15 · 2024: 15 · 2023: 28 · 2022: 25 · 2021: 36 · 2020: 21 · 2019: 23 · 2018: 23 · 2017: 38 · 2016: 32 · 2015: 26 · 2014: 46 · 2013: 22 · 2012: 30
- FWCI
- 11.63
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Cancer Cell (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Cancer Institute (R01CA057341, CA91596, CA 51497, P50CA103175, R37CA051497, R01CA091596, R01CA051497)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Redox biology and oxidative stress
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cancer and biochemical research
- Keywords
- antioxidants, HIF-1, anti-tumorigenic effects, prolyl hydroxylase 2, von Hippel-Lindau protein, N-acetylcysteine, vitamin C, reactive oxygen species, genomic instability, DNA damage, lymphoma xenografts
- MeSH terms
- Acetylcysteine, Animals, Antineoplastic Agents, Antioxidants, Ascorbic Acid, Cell Line, Humans, Mice, Transgenic, Mutation, Genomic Instability, Mice, Hypoxia-Inducible Factor 1
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
